Etienne Cartier - Concepedia

Author

Etienne Cartier

Oregon Health & Science University

Also Known As

Etienne A. Cartier, Etienne Cartier

Publications

757

Citations

H-Index

Concepts

All Affiliations

Oregon Health & Science University Delaware State University

About

Etienne Cartier is an author at Oregon Health & Science University specializing in medicine, biochemistry, and molecular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	224
2	Biochemistry	3	3	224
3	Health Sciences	1	1	70
4	Natural Sciences	1	1	15
5	Social Sciences	1	1	139

Etienne Cartier

Publications

744

Citations

H-Index

Page 1

	Year	Citations
Defective trafficking and function of K <sub>ATP</sub> channels caused by a sulfonylurea receptor 1 mutation associated with persistent hyperinsulinemic hypoglycemia of infancy Etienne Cartier, Lisa Conti, Carol A. Vandenberg, Proceedings of the National Academy of Sciences	2001	165
A Biochemical and Functional Protein Complex Involving Dopamine Synthesis and Transport into Synaptic Vesicles Etienne Cartier, Leonardo A Parra‐Rivas, Tracy Baust, Journal of Biological Chemistry Synaptic TransmissionNeurotransmitterMolecular BiologyCytoskeletonNeurotransmission	2009	139
Sulfonylureas Correct Trafficking Defects of ATP-sensitive Potassium Channels Caused by Mutations in the Sulfonylurea Receptor Feifei Yan, Elizabeth Weisiger, Etienne Cartier, Journal of Biological Chemistry	2004	106
Rare Autism-Associated Variants Implicate Syntaxin 1 (STX1 R26Q) Phosphorylation and the Dopamine Transporter (hDAT R51W) in Dopamine Neurotransmission and Behaviors Etienne Cartier, Peter J. Hamilton, Andrea N. Belovich, EBioMedicine	2015	77
Role of ubiquitin-proteasome degradation pathway in biogenesis efficiency of β-cell ATP-sensitive potassium channels Fei-Fei Yan, Etienne Cartier, Show‐Ling Shyng American Journal of Physiology-Cell Physiology Biogenesis EfficiencyProteasomeInsulin SignalingCellular PhysiologyUbiquitin-proteasome Degradation Pathway	2005	70
Molecular Interaction of the Antagonist N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1- (2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide with the CB<sub>1</sub>Cannabinoid Receptor Joong‐Youn Shim, William J. Welsh, Etienne Cartier, Journal of Medicinal Chemistry	2002	64
Parkin-independent mitophagy via Drp1-mediated outer membrane severing and inner membrane ubiquitination Yumiko Oshima, Etienne Cartier, Liron Boyman, The Journal of Cell Biology	2021	47
Modulation of the Trafficking Efficiency and Functional Properties of ATP-sensitive Potassium Channels through a Single Amino Acid in the Sulfonylurea Receptor Etienne Cartier, Shu Shen, Show‐Ling Shyng Journal of Biological Chemistry	2003	26
The SUMO-Conjugase Ubc9 Prevents the Degradation of the Dopamine Transporter, Enhancing Its Cell Surface Level and Dopamine Uptake Etienne Cartier, Jennie García‐Olivares, Eric Janezic, Frontiers in Cellular Neuroscience	2019	25
The SUMO Conjugase Ubc9 Protects Dopaminergic Cells from Cytotoxicity and Enhances the Stability of α-Synuclein in Parkinson’s Disease Models Dinesh Verma, Anurupa Ghosh, Lindsey Ruggiero, eNeuro Cell DeathMolecular BiologySynaptic SignalingDopaminergic CellsOxidative Stress	2020	15

Page 1